Canaccord Genuity Maintains Buy on Bioceres Crop Solutions, Lowers Price Target to $7
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $9.5 to $7.
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $9.5 to $7.